Bruce G. Pollock

Active 1988–2025

132
Papers
21,304
Citations
87
h-index
127
i10-index

Citations

Citations per year for Bruce G. Pollock1965: 1 citations1990: 2 citations1991: 3 citations1992: 1 citations1993: 3 citations1994: 7 citations1995: 6 citations1996: 17 citations1997: 15 citations1998: 16 citations1999: 18 citations2000: 41 citations2001: 67 citations2002: 95 citations2003: 108 citations2004: 128 citations2005: 142 citations2006: 177 citations2007: 187 citations2008: 221 citations2009: 245 citations2010: 209 citations2011: 240 citations2012: 205 citations2013: 228 citations2014: 231 citations2015: 192 citations2016: 177 citations2017: 124 citations2018: 136 citations2019: 533 citations2020: 508 citations2021: 493 citations2022: 395 citations2023: 248 citations2024: 435 citations2025: 188 citations2026: 9 citations1966–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,372 citing papers, 29.3% of this breakdownUnited Kingdom: 664 citing papers, 8.2% of this breakdownCanada: 589 citing papers, 7.3% of this breakdownChina: 468 citing papers, 5.8% of this breakdownGermany: 354 citing papers, 4.4% of this breakdownItaly: 341 citing papers, 4.2% of this breakdownAustralia: 317 citing papers, 3.9% of this breakdownNetherlands: 309 citing papers, 3.8% of this breakdownFrance: 198 citing papers, 2.5% of this breakdownSpain: 189 citing papers, 2.3% of this breakdownJapan: 164 citing papers, 2% of this breakdownSweden: 143 citing papers, 1.8% of this breakdown
0%29.3%Other 24.5%

Fields

  • Medicine59.8%
  • Neuroscience19.4%
  • Psychology8%
  • Biochemistry, Genetics and Molecular Biology3.6%
  • Health Professions1.8%
  • Social Sciences1.6%
  • Other5.8%

Topics

  • Dementia and Cognitive Impairment Research5.8%
  • Treatment of Major Depression5%
  • Schizophrenia research and treatment3.8%
  • Functional Brain Connectivity Studies3.5%
  • Tryptophan and brain disorders3.2%
  • Alzheimer's disease research and treatments2.3%
  • Other76.4%

Coauthors

All papers

Open in search
  1. Contribution of alcohol use disorders to the burden of dementia in France 2008–13: a nationwide retrospective cohort study

    Authors: , , , , , , , , - The Lancet Public Health 2018 cited by 337

  2. Effect of Citalopram on Agitation in Alzheimer Disease

    Authors: , , , , , , , , , , , , , , , , , - JAMA 2014 cited by 565

  3. Regression Models in Clinical Studies: Determining Relationships Between Predictors and Response

    Authors: , , - JNCI Journal of the National Cancer Institute 1988 cited by 971

  4. Extent of Dorsolateral Prefrontal Cortex Plasticity and Its Association With Working Memory in Patients With Alzheimer Disease

    Authors: , , , , , , , , , , - JAMA Psychiatry 2017 cited by 187

  5. Beta to theta power ratio in EEG periodic components as a potential biomarker in mild cognitive impairment and Alzheimer’s dementia

    Authors: , , , , , , , , , , , , , , - Alzheimer s Research & Therapy 2023 cited by 68

  6. The Anticholinergic Drug Scale as a Measure of Drug‐Related Anticholinergic Burden: Associations With Serum Anticholinergic Activity

    Authors: , , , , - The Journal of Clinical Pharmacology 2006 cited by 662

  7. The Nature and Determinants of Neuropsychological Functioning in Late-LifeDepression

    Authors: , , , , , , , , , , , - Archives of General Psychiatry 2004 cited by 620

  8. The Cognitive Cost of Anticholinergic Burden: Decreased Response to Cognitive Training in Schizophrenia

    Authors: , , , , , - American Journal of Psychiatry 2009 cited by 216

  9. Association of plasma biomarkers with cognition, cognitive decline, and daily function across and within neurodegenerative diseases: Results from the Ontario Neurodegenerative Disease Research Initiative

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John F. Robinson, Ekaterina Rogaeva, Demetrios J. Sahlas, Gustavo Saposnik, Michael J. Strong, Richard H. Swartz, David F. Tang‐Wai, Maria Carmela Tartaglia, Angela K. Troyer, Hlin Kvartsberg, Henrik Zetterberg, Douglas P. Munoz, the ONDRI Investigators, Mario Masellis - Alzheimer s & Dementia 2023 cited by 55

  10. Mood Disorders in the Medically Ill: Scientific Review and Recommendations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher O’Connor, John M. Petitto, Bruce G. Pollock, Robert G. Robinson, Steven P. Roose, Julia H. Rowland, Yvette I. Sheline, David S. Sheps, Gregory E. Simon, David Spiegel, Albert J. Stunkard, Trey Sunderland, Paul A. Tibbits, William J. Valvo - Biological Psychiatry 2005 cited by 1,074

  11. Anticholinergic Activity of 107 Medications Commonly Used by Older Adults

    Authors: , , , , , , , , , - Journal of the American Geriatrics Society 2008 cited by 494

  12. In-vivo imaging of grey and white matter neuroinflammation in Alzheimer’s disease: a positron emission tomography study with a novel radioligand, [18F]-FEPPA

    Authors: , , , , , , , , , - Molecular Psychiatry 2015 cited by 128

  13. Dorsolateral prefrontal cortex excitability abnormalities in Alzheimer's Dementia: Findings from transcranial magnetic stimulation and electroencephalography study

    Authors: , , , , , , , , , , - International Journal of Psychophysiology 2021 cited by 39

  14. Drugs with anticholinergic properties: a current perspective on use and safety

    Authors: , - Expert Opinion on Drug Safety 2011 cited by 191

  15. A Genetic Algorithm-Based, Hybrid Machine Learning Approach to Model Selection

    Authors: , , , , , - Journal of Pharmacokinetics and Pharmacodynamics 2006 cited by 132

  16. Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer’s Dementia: Evidence From the CitAD Study

    Authors: , , , , , , , , , , , , , , , , - American Journal of Psychiatry 2016 cited by 99

  17. Cognitive correlates of antisaccade behaviour across multiple neurodegenerative diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Demetrios J. Sahlas, Gustavo Saposnik, Dallas Seitz, Christen Shoesmith, Thomas Steeves, Stephen C. Strother, Kelly M. Sunderland, Richard H. Swartz, Brian Tan, David F. Tang‐Wai, Maria Carmela Tartaglia, John Turnbull, Lorne Zinman, Douglas P. Munoz, the ONDRI Investigators, Sabrina Adamo, Robert Bartha, Courtney Berezuk, Alanna Black, Michael Borrie, Susan E. Bronskill, Dennis E. Bulman, Leanne K. Casaubon, Ben Cornish, Sherif Defrawy, Allison A. Dilliott, Roger A. Dixon, Sali M.K. Farhan, Frederico Faria, Julia Fraser, Morris Freedman, Mahdi Ghani, Barry Greenberg, Hassan Haddad, Ayman Hassan, Wendy Hatch, Rob Hegele, Melissa F. Holmes, Chris Hudson, Mandar Jog, Peter Kleinstiver, Donna Kwan, Elena Leontieva, Brian Levine, Efrem D. Mandelcorn, Ed Margolin, Bill McIlroy, Manuel Montero‐Odasso, David G. Munoz, Nuwan D. Nanayakkara, Miracle Ozzoude, Joel Ramirez, Natalie Rashkovan, John F. Robinson, Ekaterina Rogaeva, Yanina Sarquis Adamson, Christopher J.M. Scott, Michael J. Strong, Sujeevini Sujanthan, Sean Symons, Athena Theyers, Angela K. Troyer, Karen Van Ooteghem, John Woulfe, Mojdeh Zamyadi - Brain Communications 2023 cited by 36

  18. Anticipating and Mitigating the Impact of the COVID-19 Pandemic on Alzheimer's Disease and Related Dementias

    Authors: , , , , - American Journal of Geriatric Psychiatry 2020 cited by 503

  19. Maintenance Treatment of Major Depression in Old Age

    Authors: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2006 cited by 478

  20. Age-related decline in white matter tract integrity and cognitive performance: A DTI tractography and structural equation modeling study

    Authors: , , , , , , , - Neurobiology of Aging 2010 cited by 305

  21. Persistence of Neuropsychologic Deficits in the Remitted State of Late-Life Depression

    Authors: , , , , , , , , - American Journal of Geriatric Psychiatry 2006 cited by 293

  22. Individual determinants of COVID-19 vaccine hesitancy

    Authors: , , , , , , , , , - PLoS ONE 2021 cited by 214

  23. Escitalopram for agitation in Alzheimer's disease (S‐CitAD): Methods and design of an investigator‐initiated, randomized, controlled, multicenter clinical trial

    Authors: , , , , , , , , , , , , , , - Alzheimer s & Dementia 2019 cited by 48

  24. Cognitive Outcomes After Antidepressant Pharmacotherapy for Late-Life Depression: A Systematic Review and Meta-Analysis

    Authors: , , , , , , , , - American Journal of Psychiatry 2024 cited by 46